Skip to main content

Main menu

  • HOME
  • CONTENT
    • Early Release
    • Featured
    • Current Issue
    • Issue Archive
    • Collections
    • Podcast
  • ALERTS
  • FOR AUTHORS
    • Information for Authors
    • Fees
    • Journal Clubs
    • eLetters
    • Submit
    • Special Collections
  • EDITORIAL BOARD
    • Editorial Board
    • ECR Advisory Board
    • Journal Staff
  • ABOUT
    • Overview
    • Advertise
    • For the Media
    • Rights and Permissions
    • Privacy Policy
    • Feedback
    • Accessibility
  • SUBSCRIBE

User menu

  • Log out
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Neuroscience
  • Log out
  • Log in
  • My Cart
Journal of Neuroscience

Advanced Search

Submit a Manuscript
  • HOME
  • CONTENT
    • Early Release
    • Featured
    • Current Issue
    • Issue Archive
    • Collections
    • Podcast
  • ALERTS
  • FOR AUTHORS
    • Information for Authors
    • Fees
    • Journal Clubs
    • eLetters
    • Submit
    • Special Collections
  • EDITORIAL BOARD
    • Editorial Board
    • ECR Advisory Board
    • Journal Staff
  • ABOUT
    • Overview
    • Advertise
    • For the Media
    • Rights and Permissions
    • Privacy Policy
    • Feedback
    • Accessibility
  • SUBSCRIBE
PreviousNext
Brief Communications

Target-Specific Suppression of GABA Release from Parvalbumin Interneurons in the Basolateral Amygdala by Dopamine

Hong-Yuan Chu, Wataru Ito, Jiayang Li and Alexei Morozov
Journal of Neuroscience 17 October 2012, 32 (42) 14815-14820; https://doi.org/10.1523/JNEUROSCI.2997-12.2012
Hong-Yuan Chu
1Unit on Behavioral Genetics, Laboratory of Molecular Pathophysiology, National Institute of Mental Health, National Institutes of Health, Bethesda, Maryland 20892, and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Wataru Ito
1Unit on Behavioral Genetics, Laboratory of Molecular Pathophysiology, National Institute of Mental Health, National Institutes of Health, Bethesda, Maryland 20892, and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jiayang Li
1Unit on Behavioral Genetics, Laboratory of Molecular Pathophysiology, National Institute of Mental Health, National Institutes of Health, Bethesda, Maryland 20892, and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alexei Morozov
1Unit on Behavioral Genetics, Laboratory of Molecular Pathophysiology, National Institute of Mental Health, National Institutes of Health, Bethesda, Maryland 20892, and
2Virginia Tech Carilion Research Institute, Virginia Tech, Roanoke, Virginia 24016
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Article Figures & Data

Figures

  • Figure 1.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 1.

    Selective activation of GABAergic transmission between PV-INs and PNs in BLA by ChR2. A, Confocal images show ChR2-tdTomato fluorescence (red) and PV-immunofluorescence (blue). Note that all ChR2-expressing cells (arrows) express PV, but only 41 ± 4% of PV-INs (n = 4 mice) express ChR2. B, Left, Whole-cell recording from a ChR2-expressing neuron. Short pulses of photostimulation (Photo-stim) evoke membrane depolarization (red, 0.2 ms pulse) and action potential (black, 0.4 ms pulse). Right, Trains of action potentials induced by continuous photostimulation (red, firing frequency = 107 Hz) or by current injection (black, firing frequency = 70 Hz). C, Blockade of light-induced IPSCs by GABAA receptor antagonist picrotoxin. D, Blockade of light-induced IPSCs by P/Q type Ca2+ channel blocker ω-agatoxin IVA. Left, IPSCs examples before (black) and after (red) ω-agatoxin IVA application. Right, Summary bar graph shows the blockade of light-induced IPSCs by ω-agatoxin IVA (*p < 0.05). E, Lack of DSI in light-induced IPSCs by a 6 s depolarization to 0 mV.

  • Figure 2.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 2.

    Selective modulation of GABAergic transmission from PV-INs to PNs by DA. A, Expression of ChR2 (left) in BLA of Cre-PV/GAD67-GFP mice (middle). B, Recording configuration. C, Top, example IPSCs evoked in a BLA pyramidal neuron by photostimulation (Photo-stim) before (black) and after (red) DA application. Bottom, Time course of the IPSC amplitude in the same cell. D, Top, Example IPSCs evoked in a BLA INs by photostimulation before (black) and after (red) DA application. Bottom, Time course of the IPSCs amplitude in the same cell. E, Summarized data for the effects of DA in BLA PNs and INs. F, DA effect on GABAergic neurotransmission from SOM-INs to PNs and INs. The red and blue traces indicate IPSCs after DA application. **p < 0.01 when compared with baseline.

  • Figure 3.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 3.

    Presynaptic D2 receptor mediates the inhibitory effects of DA in PV-IN projections to PNs. A, Top, Example traces of synaptic responses to paired-pulse stimulation before (black) and after (red) DA application. Bottom, Summary graph shows changes of paired-pulse ratio during DA application. B, Top, Example traces of muscimol-puffing-induced GABAA receptor current before (black) and after (red) DA application. Bottom, Summary graph shows muscimol-induced current during DA application. C, Top, Firing pattern of a PV-IN expressing ChR2 upon photostimulation (light) before and after DA application. Bottom, Effects of DA on membrane potential (MP; left), input resistance (Rin; middle), and number of spikes (right) in PV-INs. D, Top, Example IPSC traces before and after DA application in the presence of raclopride (Rac), and the IPSC traces before and after application of quinpirole. Bottom, Summary bar graph shows inhibition of IPSC by DA, lack of such inhibition in the presence of raclopride, and inhibition by quinpirole. Each dot represents a single cell. **p < 0.01, ***p < 0.005. n.s., Nonsignificant, when compared with baseline.

  • Figure 4.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 4.

    The role of cAMP-dependent signaling in target-specific inhibition of GABA release from PV-INs by DA. A, Specific GIRK channel inhibitor tertiapin-Q did not interfere with DA inhibition of IPSCs in PNs. Left, Time course of IPSC amplitude from an example cell. Right, Summary graph showing the effect of DA after blockade of GIRK. Each symbol represents a single neuron. B, C, Inhibitory effect of DA was blocked by cAMP competitor Rp-cAMP (B) and by PKA inhibitor H-89 (C). D, E, Rp-cAMP alone reduced the IPSC amplitude in PNs (D) but not in INs (E). F, Adenylate cyclase activator forskolin did not affect GABA release from PV-INs to INs. *p < 0.05, **p < 0.01.

Back to top

In this issue

The Journal of Neuroscience: 32 (42)
Journal of Neuroscience
Vol. 32, Issue 42
17 Oct 2012
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Advertising (PDF)
  • Ed Board (PDF)
Email

Thank you for sharing this Journal of Neuroscience article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Target-Specific Suppression of GABA Release from Parvalbumin Interneurons in the Basolateral Amygdala by Dopamine
(Your Name) has forwarded a page to you from Journal of Neuroscience
(Your Name) thought you would be interested in this article in Journal of Neuroscience.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Print
View Full Page PDF
Citation Tools
Target-Specific Suppression of GABA Release from Parvalbumin Interneurons in the Basolateral Amygdala by Dopamine
Hong-Yuan Chu, Wataru Ito, Jiayang Li, Alexei Morozov
Journal of Neuroscience 17 October 2012, 32 (42) 14815-14820; DOI: 10.1523/JNEUROSCI.2997-12.2012

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Respond to this article
Request Permissions
Share
Target-Specific Suppression of GABA Release from Parvalbumin Interneurons in the Basolateral Amygdala by Dopamine
Hong-Yuan Chu, Wataru Ito, Jiayang Li, Alexei Morozov
Journal of Neuroscience 17 October 2012, 32 (42) 14815-14820; DOI: 10.1523/JNEUROSCI.2997-12.2012
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Introduction
    • Materials and Methods
    • Results
    • Discussion
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Responses to this article

Respond to this article

Jump to comment:

No eLetters have been published for this article.

Related Articles

Cited By...

More in this TOC Section

  • Heteromodal Cortical Areas Encode Sensory-Motor Features of Word Meaning
  • Pharmacologically Counteracting a Phenotypic Difference in Cerebellar GABAA Receptor Response to Alcohol Prevents Excessive Alcohol Consumption in a High Alcohol-Consuming Rodent Genotype
  • Neuromuscular NMDA Receptors Modulate Developmental Synapse Elimination
Show more Brief Communications
  • Home
  • Alerts
  • Follow SFN on BlueSky
  • Visit Society for Neuroscience on Facebook
  • Follow Society for Neuroscience on Twitter
  • Follow Society for Neuroscience on LinkedIn
  • Visit Society for Neuroscience on Youtube
  • Follow our RSS feeds

Content

  • Early Release
  • Current Issue
  • Issue Archive
  • Collections

Information

  • For Authors
  • For Advertisers
  • For the Media
  • For Subscribers

About

  • About the Journal
  • Editorial Board
  • Privacy Notice
  • Contact
  • Accessibility
(JNeurosci logo)
(SfN logo)

Copyright © 2025 by the Society for Neuroscience.
JNeurosci Online ISSN: 1529-2401

The ideas and opinions expressed in JNeurosci do not necessarily reflect those of SfN or the JNeurosci Editorial Board. Publication of an advertisement or other product mention in JNeurosci should not be construed as an endorsement of the manufacturer’s claims. SfN does not assume any responsibility for any injury and/or damage to persons or property arising from or related to any use of any material contained in JNeurosci.